Drug Type Molecular glue |
Synonyms GT 919, GT-919, GT919 |
Target |
Mechanism IKZF1 inhibitors(DNA-binding protein Ikaros inhibitors), IKZF3 inhibitors(Zinc finger protein Aiolos inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Phase 1 | CN | 03 Jul 2023 | |
Hematologic Neoplasms | IND Approval | US | 24 May 2023 |